Coca-Cola Europacific Partners PLC (CCEP) Stock Analysis
Is CCEP a good investment?
Coca-Cola Europacific Partners PLC (CCEP) has a Plutrex AI rating of 52.0/100 as of August 20, 2026, indicating a Hold consensus. The stock is not classified as halal-compliant. Key strength: FCF of $1.583 billion (meaningful FCF yield on market cap) provides robust debt service capacity, supports the buyback program, and anchors downside — the €2.04 full-year dividend declared confirms management's confidence in cash generation sustainability. Main concern: PEG ratio of 2.08x (worsened from 2.06x prior week) remains the primary red flag — at a fair PEG of 1.0-1.5x on 9.1% forward growth, intrinsic value is approximately $47-$71 per share on a pure growth-adjusted basis, or $71-$80 applying a generous 1.5x PEG premium for FCF quality; analyst consensus target of $110.51 implies only 3.6% upside from $106.68, providing essentially zero margin of safety for new buyers.
Investment Summary
Coca-Cola Europacific Partners (CCEP) at $106.68 remains a Hold — a quality beverage bottler with predictable cash flows but a price that offers essentially no margin of safety. The core thesis is unchanged from 7 days ago: PEG ratio of 2.08x (slightly worsened from 2.06x) is the primary overvaluation signal, with analyst consensus target of $110.51 implying only 3.6% upside. The business is fundamentally sound — FCF of $1.58 billion, ROE of 24.6%, and consistent 9.0-9.2% EPS growth — but the stock is priced for perfection. News sentiment is strongly positive (89.9/100) with a €2.04 full-year dividend declared and higher H1 profit reported, yet the headline 'Coca-Cola Europacific shares lose fizz after interim results' confirms the market has already priced in the good news. P/E of 20.63x trades at a 48% discount to the industry average of 39.75x, but the PEG of 2.08x is essentially in line with the industry average of 2.15x — confirming no genuine growth-adjusted value advantage. D/E of 1.27x remains 28.9% above the industry average of 0.985x. Current price of $106.68 is 12.3% above the top of my entry range of $90-$95. Existing holders should hold; new buyers should wait for the $90-$95 entry zone.
Key Strengths
- FCF of $1.583 billion (meaningful FCF yield on market cap) provides robust debt service capacity, supports the buyback program, and anchors downside — the €2.04 full-year dividend declared confirms management's confidence in cash generation sustainability
- Forward next-year EPS growth of 9.2% modestly beats the industry average of 8.4%, and historical earnings growth of 9.0% aligns precisely with the 5-year forward projection of 9.1%, creating a credible, consistent, and predictable earnings compounding narrative
- P/E of 20.63x trades at a 48% discount to the industry average of 39.75x, and H1 2026 profit came in higher than expected per interim results — near-term earnings momentum is intact and the absolute multiple is lower than most peers
Key Concerns
- PEG ratio of 2.08x (worsened from 2.06x prior week) remains the primary red flag — at a fair PEG of 1.0-1.5x on 9.1% forward growth, intrinsic value is approximately $47-$71 per share on a pure growth-adjusted basis, or $71-$80 applying a generous 1.5x PEG premium for FCF quality; analyst consensus target of $110.51 implies only 3.6% upside from $106.68, providing essentially zero margin of safety for new buyers
- D/E of 1.27x is 28.9% above the industry average of 0.985x, amplifying financial risk; the headline 'Coca-Cola Europacific shares lose fizz after interim results' and 'Valuation Got Even More Stretched' confirm the market recognizes the stock is fully priced — good news is already in the price, and the stock fell 0.4% this week despite positive news flow
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
CCEP's fundamentals reflect a mature, capital-intensive beverage bottler with predictable but unexciting economics. Profitability: Gross margin of 35.0% is 20.9% below the industry average of 44.19%, reflecting the structural cost burden of bottling/distribution vs. brand ownership. Operating margin of 13.4% trails the industry average of 17.74% by 24.5%. Net margin of 9.3% is below the industry average of 10.77%. ROE of 24.6% appears strong but is 16.1% below the industry average of 29.38% and is amplified by D/E of 1.27x — underlying asset-level returns are even more disadvantaged. Valuation: P/E of 20.63x is 48% below the industry average of 39.75x, but PEG of 2.08x is essentially in line with the industry average of 2.15x — the P/E discount is fully explained by lower growth, not hidden value. At 9.1% forward EPS growth, a fair P/E would be 9-15x using growth-rate parity, suggesting 37-130% overvaluation on that basis. Financial Health: D/E of 1.27x vs. industry average of 0.985x. Cash of $1.994 billion and FCF of $1.583 billion provide adequate liquidity and debt service capacity. Growth: Revenue growth of 4.4% is 67.7% below the industry average of 13.61%. Forward next-year EPS growth of 9.2% modestly beats the industry average of 8.4% — the one forward metric where CCEP leads. Five-year forward EPS growth of 9.06% lags the industry average of 11.44% by 20.8%. Analyst consensus target of $110.51 implies only 3.6% upside from $106.68 — essentially no margin of safety.
News Sentiment
Coca-Cola Europacific Partners is delivering solid results — but Wall Street isn't exactly popping the champagne. The European and Pacific bottling giant reported higher first-half profits in its interim results, a genuine win for a company navigating currency headwinds and shifting consumer tastes. The company also declared a full-year dividend of €2.04 per share, signaling management's confidence that the cash keeps flowing. But here's the catch: even good news couldn't keep the stock fizzing. The headline 'Coca-Cola Europacific shares lose fizz after interim results' tells the real story — investors had already priced in the positive results, and the stock drifted lower anyway. A separate analysis titled 'Valuation Got Even More Stretched' captures the market's dilemma perfectly: CCEP is executing well, but the stock price has run ahead of the fundamentals. On the bright side, institutional investors are taking notice — new fund positioning highlights CCEP alongside other growth-oriented investments, suggesting smart money sees long-term value in the franchise. And one bullish piece argues 'Earnings Can Keep Compounding,' pointing to CCEP's consistent 9% annual EPS growth as a reason for patience. The bottom line for everyday investors: CCEP is a solid, dividend-paying business with predictable earnings — but at current prices near $107, you're paying full price for a steady compounder with only about 3.6% upside to analyst targets. The opportunity comes if the stock pulls back to the $90-$95 range.
Risk Assessment
Primary risk: Valuation compression if interest rates remain elevated — at PEG 2.08x with D/E 1.27x, any earnings miss or guidance cut could trigger a 15-25% de-rating. Secondary risk: Currency headwinds — FX-neutral revenue and profit growth outpacing reported figures (per news analysis) means reported results will continue to disappoint relative to underlying performance as long as the USD remains strong against EUR/AUD/NZD. Mitigation: CCEP's $1.58 billion FCF provides a meaningful floor — at $90 entry, FCF yield would be approximately 1.76% on market cap, providing downside support. The Coca-Cola franchise relationship provides revenue visibility and limits catastrophic downside. Stop loss at $86.00 (6.9% below entry midpoint of $92.50) limits maximum loss to approximately 7% from entry, while the risk/reward to Target 1 ($110.51) is 2.77x from midpoint. Existing holders face limited downside given FCF support but should not add at current prices.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is CCEP a halal stock?
No, Coca-Cola Europacific Partners PLC (CCEP) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for CCEP?
Coca-Cola Europacific Partners PLC (CCEP) has a Plutrex AI rating of 52.0/100 with a Hold consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is CCEP a good investment?
According to Plutrex AI, CCEP has a Hold rating (52.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in CCEP?
US stocks like CCEP can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in CCEP?
Plutrex AI identifies the main risks for CCEP by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.